Gonadotropin-Releasing Hormone Agonists for Endometriosis

descriptionPublicationkeyboard_double_arrow_right Article 11 Sep 2008 English Publisher:Massachusetts Medical SocietyJournal:New England Journal of Medicine, volume 359, pages 1,136-1,142 (issn: 0028-4793, eissn: 1533-4406,

Copyright policy )

Authors: David L, Olive;

doi: 10.1056/nejmct0803719

pmid: 18784103

Gonadotropin-Releasing Hormone Agonists for Endometriosis

- Summary
- Subjects
- Metrics

Abstract

A 36-year-old woman with a presumptive diagnosis of endometriosis presents with long-standing pelvic pain that is not relieved by means of oral contraceptives or medroxyprogesterone. Treatment with a gonadotropin-releasing hormone agonist is recommended. Gonadotropin-releasing hormone agonists profoundly suppress gonadotropin secretion and sex-steroid production. Side effects include loss of bone mineral density and memory impairment.

Keywords

Adult, Gonadotropin-Releasing Hormone, Bone Density, Practice Guidelines as Topic, Endometriosis, Humans, Pain, Female

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	43
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%